Schroder Investment Management Group raised its stake in shares of MetLife, Inc. (NYSE:MET) by 7.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 401,677 shares of the financial services provider’s stock after buying an additional 29,086 shares during the quarter. Schroder Investment Management Group’s holdings in MetLife were worth $20,614,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently made changes to their positions in MET. Epoch Investment Partners Inc. purchased a new position in shares of MetLife in the second quarter valued at $183,290,000. TD Asset Management Inc. grew its holdings in shares of MetLife by 47.7% in the second quarter. TD Asset Management Inc. now owns 5,201,238 shares of the financial services provider’s stock valued at $285,756,000 after purchasing an additional 1,679,740 shares in the last quarter. Prudential Financial Inc. grew its holdings in shares of MetLife by 71.4% in the second quarter. Prudential Financial Inc. now owns 3,672,729 shares of the financial services provider’s stock valued at $201,778,000 after purchasing an additional 1,529,570 shares in the last quarter. BlackRock Inc. grew its holdings in shares of MetLife by 2.2% in the second quarter. BlackRock Inc. now owns 69,957,359 shares of the financial services provider’s stock valued at $3,843,457,000 after purchasing an additional 1,481,489 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new position in shares of MetLife in the second quarter valued at $76,823,000. 76.37% of the stock is owned by institutional investors and hedge funds.
MetLife, Inc. (MET) traded up $0.01 during trading hours on Tuesday, hitting $53.62. The stock had a trading volume of 4,118,600 shares, compared to its average volume of 5,744,903. MetLife, Inc. has a fifty-two week low of $44.26 and a fifty-two week high of $55.91. The company has a market capitalization of $56,360.00, a P/E ratio of 10.31, a price-to-earnings-growth ratio of 1.35 and a beta of 1.49. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 13th. Stockholders of record on Monday, November 6th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 3rd. This represents a $1.60 annualized dividend and a dividend yield of 2.98%. MetLife’s dividend payout ratio (DPR) is 347.83%.
A number of research analysts recently weighed in on the stock. Langen Mcalenn reissued a “buy” rating on shares of MetLife in a report on Wednesday, August 16th. ValuEngine upgraded MetLife from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 11th. Zacks Investment Research downgraded MetLife from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. BidaskClub upgraded MetLife from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. Finally, Argus lowered their price target on MetLife from $60.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday, August 9th. One research analyst has rated the stock with a sell rating, ten have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. MetLife has an average rating of “Buy” and an average price target of $58.40.
In related news, insider Christopher G. Townsend sold 82,731 shares of MetLife stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $54.60, for a total value of $4,517,112.60. Following the completion of the sale, the insider now directly owns 49,660 shares in the company, valued at $2,711,436. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christopher G. Townsend sold 55,712 shares of MetLife stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $54.29, for a total value of $3,024,604.48. Following the completion of the sale, the insider now owns 25,181 shares of the company’s stock, valued at $1,367,076.49. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY NOTICE: “MetLife, Inc. (MET) Shares Bought by Schroder Investment Management Group” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://sportsperspectives.com/2017/12/05/metlife-inc-met-shares-bought-by-schroder-investment-management-group.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).
Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.